RxDoctor Payments Data

Bhagwan Sayal, MD

Family Medicine · Flint, MINPI 1881796555

Payments from drug & device makers

$5,617in general payments, 2019–2025

Across 330 payments — averaging $17.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$909
  • Novo Nordisk$691
  • AstraZeneca$597
  • AbbVie$510
  • Pfizer$340
  • Lilly USA, LLC$272
  • plus $2K from 29 others

What the payments were for

  • Food & beverage$5,617100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$5,617 in reported general payments places this provider in the 90th percentile of 3,945 family medicine providers in Michigan.

See all family medicine providers in Michigan

Medicare billing

Part B allowed, 2024
$63,021
Medicare patients
93
Services billed
1,482

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide79$136,021
TrulicityDulaglutide49$72,580
EliquisApixaban53$61,886
JardianceEmpagliflozin41$54,035
XareltoRivaroxaban55$43,086
FarxigaDapagliflozin Propanediol46$42,523
ProliaDenosumab17$28,710
MounjaroTirzepatide16$19,074
CreonLipase/Protease/Amylase12$17,262
Levemir FlexpenInsulin Detemir11$6,484
Atorvastatin Calcium291$5,422
Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate11$5,028
Lantus SolostarInsulin Glargine,hum.Rec.Anlog15$4,914
Levothyroxine Sodium348$4,253
Potassium Chloride198$4,074

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$691$136,02179 claims
Lilly USA, LLCTrulicity, Mounjaro$272$91,65465 claims
PfizerEliquis$340$61,88653 claims
Boehringer IngelheimJardiance$108$54,03541 claims
Johnson & JohnsonXarelto$86$43,08655 claims
AstraZenecaFarxiga$597$42,52346 claims
AmgenProlia$909$28,71017 claims
AbbVieCreon$510$17,26212 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,945 family medicine providers in Michigan.

Other family medicine in Flint

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →